Skip to main content
. 2020 Jul 17;36:101646. doi: 10.1016/j.redox.2020.101646

Table 2.

Summarized effects on TrxR1 by explored STAT3 inhibitors.

Compound Inhibition of purified TrxR1 Inhibition of cellular TrxR1 Tm with NADPH Tm without NADPH Substrate of TrxR1
Auranofin ++++ ++ 46.4 °C 66.6 °C
Stattic +++ +++ 66.6 °C 66.4 °C +
S3I-1757 +++ 50.8 °C 67.2 °C
5,15-DPP ++ ++ 50.6 °C 67.2 °C
Galiellalactone ++ + 50.6 °C 66.6 °C
LLL12 ++ ++ 69.0 °C 66.5 °C +
Cpd188 + 68.0 °C 67.4 °C +
Napabucasin + + 68.4 °C 67.2 °C +
BP1-102 + +
STA-21 + + 52.4 °C 66.9 °C
inS3-54 + 51.8 °C 66.6 °C
SH-4-54 + 51.0 °C 67.9 °C
S3I-201 + + 51.2 °C 67.3 °C
STX-0119 (+) 51.4 °C 67.1 °C
Degrasyn (WP1130) ++ ++ 52.5 °C 66.5 °C
WP1066 + 52.4 °C 65.7 °C
Cucurbitacin I (JSI-124) (+) 52.8 °C 66.9 °C
Tyrphostin B42 (AG490) (+) 51.5 °C 66.8 °C
Cryptotanshinone ++ 62.9 °C 66.9 °C +
Disulfiram + 58.3 °C 58.8 °C +
Pyrimethamine 50.9 °C 66.5 °C
Celecoxib 51.2 °C 66.7 °C
Atovaquone 50.4 °C 66.8 °C

Underlining is indicative of a signficant change in Tm compared to DMSO-treated TrxR1.